EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

HSV-1 as a Potential Driver of Alzheimer’s Disease

Dar-Yin Li iD, Eun Seok Choi iD, Xiaoyong Bao iD

Pathogens · 08.10.2025 · 14 (10) · 1022

DOI: 10.3390/pathogens14101022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 08.10.2025. Verfasst von Dar-Yin Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX 77555, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Herpesvirus 1, Human, Herpes Simplex. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, American Lung Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex virus type 1 (HSV-1) is a continuous health challenge, and current antiviral treatments cannot cure the virus. As life expectancy continues to increase worldwide, HSV-1 should remain a focus to minimize its associated health complications within the aging population. While often asymptomatic, HSV-1 causes oral and cutaneous lesions and establishes latency with periodic reactivation. Antivirals reduce symptoms but do not eradicate the virus. Emerging evidence links HSV-1 to Alzheimer’s disease (AD) via chronic neuroinflammation, amyloid-beta and tau accumulation, oxidative stress, and synaptic dysfunction, with viral proteins detected in AD-affected brain regions. This review assesses the current evidence for HSV-1 in dementia pathogenesis, examines antiviral strategies as potential neuroprotective interventions, and outlines the experimental models required to establish causality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHerpesvirus 1, HumanHerpes SimplexHumansAnimalsAntiviral AgentsAmyloid beta-Peptidestau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseHSV-1HSV-1 experimental modelsdementia pathogenesis

Substanzen

Antiviral AgentsAmyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • Department of Pediatrics, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • The Institute of Translational Sciences, The University of Texas Medical Branch, Galveston, TX 77555, USA.
  • The Institute of Human Infections and Immunity, The University of Texas Medical Branch, Galveston, TX 77555, USA.

ORCID-Profile: Dar-Yin Li, Eun Seok Choi, Xiaoyong Bao

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • American Lung Association
  • NIA NIH HHS
  • TARCC
  • US National Institutes of Health (NIH)
  • TARRC

Zitieren

APA

Li, D. Y., Choi, E. S., & Bao, X. (2025). HSV-1 as a Potential Driver of Alzheimer’s Disease. Pathogens, 14(10), 1022. https://doi.org/10.3390/pathogens14101022

Vancouver

Li DY, Choi ES, Bao X. HSV-1 as a Potential Driver of Alzheimer’s Disease. Pathogens. 2025;14(10):1022. doi:10.3390/pathogens14101022

BibTeX
@article{Li2025,
  author = {Li, Dar-Yin and Choi, Eun Seok and Bao, Xiaoyong},
  title = {HSV-1 as a Potential Driver of Alzheimer’s Disease},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {10},
  pages = {1022},
  doi = {10.3390/pathogens14101022}
}
Kostenlos starten →